Stock screenerAll disclosures →
EDGAR →
PMCB
Conviction 20HealthcareScan · Mon, Aug 10, 2026PMCB$0.5554-5.88%
ResistanceSupportVol 14Vol MA14 160.8K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price0.5554
Change-5.88%
Gap-0.12%
Rel volume2.66×
Avg volume143.44K
Avg $ vol86.24K
SMA 200.6087
SMA 500.6894
SMA 2000.7688
Price vs 50-19.44%
Price vs 200-27.76%
MA stackbearish
50/200 cross—
Supertrenddown · 0.6930
RSI (14)32
MACD hist0.00
MACD crossbull · 3d
Stoch %K / %D11 / 34
ADX (14)33
+DI / −DI8 / 21
RSI divergenceBullish
MACD divergenceBullish
ATR %+7.91%
ADR %6.99%
52w high1.22
52w low0.5554
From 52w high-54.48%
Above 52w low+0.00%
New 52w highNo
SqueezeOff
Bollinger width24.12%
%B0.14
Donchian pos4.85%
Donchian high0.7399
Donchian low0.5460
AVWAP (52w high)0.9923
vs AVWAP high-44.03%
AVWAP (52w low)0.5636
vs AVWAP low-1.45%
OBV trendFlat
Chaikin MF (20)-0.04
Today vs 20d2.66×
Avg vol (14d)160.8K
Avg vol (20d)143.44K
Avg $ vol (20d)86.24K
Market cap—
RS 3m (vs SPY)-31.93%
RS 6m (vs SPY)-29.81%
RS line new highNo
Trend template0/8
Technical rank9.3
1 week-3.54%
1 month-20.26%
3 months-26.51%
6 months-25.07%
1 year-34.66%
YTD-24.74%
P/E-0.32
P/B0.19
P/S—
P/FCF—
EPS-2.77
Div yield—
ROE-58.34%
ROA-41.55%
Debt/Eq0.07
Current45.28
EV/EBITDA1.44
Gross margin—
Net margin—
Rev growth—
EPS growth-163.36%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-9.85M
Revenue0
Net income746.86K
Gross profit0
Free cash flow—
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out10.74M
Employees2
ListedThu, Sep 11, 2003
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction20 / 100
Pattern quality—
Tech rank9.3 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.7666
Support0.5605
Days since event—
Candle confirm—
News sentiment—
Financials as of Sat, Jan 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PMCB
No recent disclosed trades by Congress in PMCB. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PMCB · 4 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
WALKER WAYNE REMELL Director · Stock Option (Right to Buy) · 2026-03-31 | Acquire | 0 | — | 2026-03-31 | 2026-07-17 |
Abecassis Michael M Director · Stock Option (Right to Buy) · 2026-03-31 | Acquire | 0 | — | 2026-03-31 | 2026-07-17 |
WEINSTEIN ROBERT Director · Stock Option (Right to Buy) · 2026-03-31 | Acquire | 0 | — | 2026-03-31 | 2026-07-17 |
SCHECHTER JONATHAN Director · Stock Option (Right to Buy) · 2026-03-31 | Acquire | 0 | — | 2026-03-31 | 2026-07-17 |
SEC filings
EDGAR filings in PMCB · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.